BREEN CAPITAL (“BREEN”) is a hybrid incubator, principal investor, and operator in global projects at scale which generate both long term financial outperformance and deep rooted environmental, social and humanitarian outcomes.
Our extensive global network of business, academic, research, and governmental leaders allows us to be sector agnostic. However, in order to deliver both world-class financial performance and robust ESG outcomes, most of our projects are in energy, recovery (waste management), housing, healthcare, agriculture, and other impactful businesses and technologies. They tend to be either:
-
Project finance delivering long term structural improvements (energy, waste management, housing) to communities and economies in both established markets and low- and middle-income countries. These projects tend to be higher capex, longer term with a complex set of agreements, and can take years of BREEN preparation and investment to bring to fruition with BREEN’s in country relationships.
-
Unique combinations of early-stage venture capital, private equity, and distribution agreements to bring cutting edge healthcare, agriculture, and other impactful technologies to low- and middle-income countries at the same time as they are being commercialised in the US and Europe.
We bring together our long-standing European and US academic and research partners with in-country academics / institutions to collaborate on research, product development, and to publish in leading journals. We have found this to be essential in raising the quality of life for the long term in the low-and middle-income countries we focus on.
History
The breadth and ambition of BREEN CAPITAL was born of the entrepreneurial creativity and common-sense tenacity of founder and Chairman Bobby (Bob) Breen, who over decades has grown the business from his humble “working class” Irish origins to the global reach of today. He built a loyal network of limited partners to whom he gave not only strong returns and his creative business mind, but he also set an example by giving back to organisations serving those less fortunate than him.
As the business grew he developed a reputation for securing and re-planning key residential and mixed-use real estate sites in the UK. This in turn led to similar investments in the US and Europe with an increasing focus on affordable housing, thereby mitigating the cyclicality of the private housing market and locking in long term quasi-governmental income streams while addressing a vital unmet need.
The search for returns underpinned by sovereign covenants whilst also delivering essential services and infrastructure inevitably led him to the low- and middle-income countries that are home to the majority of the world’s population who are afflicted with hunger, limited access to clean water, energy poverty, poor housing, healthcare and security, and limited educational and employment opportunities. Here he established long-term partnerships with governments, seeking to attract inward investment into key national infrastructure. These partnerships have in turn led to the development of milestone renewable energy projects that to this day continue to meet electricity demands across the continent.
Building on these global relationships and the imperative to generate long term value whilst benefitting populations in low- and middle-income countries, he then developed an investment strategy in the areas of novel diagnostics, therapeutics, and pharmaceuticals. This strategy focuses on investing in products with significant global IP, a comprehensive manufacturing strategy, and a pricing structure that allows multiple distribution channels in many different private & public healthcare markets around the world.
As unorthodox as we are effective, BREEN CAPITAL has evolved out of Bobby’s early experiences in business to choose partners for the long term who want to be “told the way it is, not the way they’d like it to be”, who value discretion, respect our different roles in making a project a success, and above all who understand and believe in the BREEN vision.
From The Pen Of The Chairman
